Broadwood Partners seeks to remove three STAAR Surgical directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
December 2, 2025 4:15 PM ESTPursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process
Broadwood Seeks to Remove the Directors Most Responsible for the Flawed Sale Process: Board Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Arthur Butcher
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the Special Meeting) at STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More



